Heart rate reduction in cardiovascular disease and therapy.
about
Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study.Hot topics in cardiology: data from IABP-SHOCK II, TRILOGY-ACS, WOEST, ALTIDUDE, FAME II and more.Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials.Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practiceSystems Pharmacology Dissecting Holistic Medicine for Treatment of Complex Diseases: An Example Using Cardiocerebrovascular Diseases Treated by TCMThe Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: implementation of a nationwide patient enrollment system.Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA ConsortiumHeart failure in elderly: progress in clinical evaluation and therapeutic approach.Treating resistant hypertension: role of renal denervation.Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.Effects of renal sympathetic denervation on cardiac systolic function after myocardial infarction in ratsIvabradine: potential clinical applications in critically ill patients.Renal sympathetic denervation: applications in hypertension and beyond.Novel and nonpharmacologic approaches to cardio-protection in hypertension.Water ingestion decreases cardiac workload time-dependent in healthy adults with no effect of gender.Etiology-specific assessment of predictors of long-term survival in chronic systolic heart failurePrognostic relevance of heart rate at rest for survival and the quality of life in patients with dilated cardiomyopathy.Heart rate differentiates urgency and emergency in hypertensive crisis.Portable recording for detecting sleep disorder breathing in patients under the care of a heart failure clinic.Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure.Outcome quality of in-patient cardiac rehabilitation in elderly patients--identification of relevant parameters.If Channel as an Emerging Therapeutic Target for Cardiovascular Diseases: A Review of Current Evidence and Controversies.Adverse effects of permanent atrial fibrillation on heart failure in patients with preserved left ventricular function and chronic right apical pacing for complete heart block.Electrical myostimulation improves left ventricular function and peak oxygen consumption in patients with chronic heart failure: results from the exEMS study comparing different stimulation strategies.Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND.[Acute and chronic heart failure in light of the new ESC guidelines].
P2860
Q30318221-D561A92D-A444-4D1C-841C-0F771DD26D44Q30318280-503F988C-8104-40F4-B0CF-D24F923323C1Q30573351-352FE0B7-393D-4B6D-B37D-43344BE93E5EQ33617828-E60F33A2-A2C9-4F0A-B962-9AA030343927Q34253493-5D8053F8-B446-4A15-9E6D-1297E06A6493Q35697884-AEC61D05-1735-4378-8F97-AC1C640C97F8Q36311784-F6A5E99C-BC7B-4338-B18C-12D25BC20566Q36384352-7D61F49C-63EE-4C74-9910-40D80B085D96Q37001576-001881DD-B3AF-44B8-A16D-7A57C6501E51Q37218107-373685FE-1099-4B7F-AC1C-1350F2DF8767Q37250491-BEB65C12-59A8-42E8-B952-328C3B234D8DQ37300112-5B6B1CD4-6448-4632-A531-079DBA4B136CQ38052022-F30B98F0-DC6A-4D4C-AF79-AA7AFA659BD7Q38115114-1F3B0448-5EFA-4F85-96CE-BA555DFADFC8Q38196355-5E1BDDC3-F4EF-4994-BF27-0AF36654E74CQ38628095-63515EFF-E1E7-4A09-AC60-E0C8D649A8A3Q38635724-71A13D9A-E7DC-49FA-99D1-053105F8A410Q39635805-DC3CF828-8E0B-440F-9645-4C30B8F67886Q41969828-0031B732-E4E4-438C-B2D2-FE50230E49FEQ43984933-0D8F6B5F-8F38-4D37-B31C-AAC005A4D06AQ45301370-5C4FCE43-602B-4F89-9FB2-296CBECAA5EAQ45326564-273626CC-CD07-4986-A894-E631205D75DDQ47114756-2B5614A1-0D90-4E5A-804C-8FD86637DDBDQ48511434-1FAE7546-99A4-4B80-AE6E-64428ECCB88DQ51818569-96E94989-D069-4E90-813B-77C3EF45B60DQ54414947-65DFD23D-C567-4B23-8943-16509643A7C1Q54716857-7B253D54-01F0-492C-8F84-42763FBC5DB2
P2860
Heart rate reduction in cardiovascular disease and therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Heart rate reduction in cardiovascular disease and therapy.
@en
Heart rate reduction in cardiovascular disease and therapy.
@nl
type
label
Heart rate reduction in cardiovascular disease and therapy.
@en
Heart rate reduction in cardiovascular disease and therapy.
@nl
prefLabel
Heart rate reduction in cardiovascular disease and therapy.
@en
Heart rate reduction in cardiovascular disease and therapy.
@nl
P2093
P2860
P50
P1476
Heart rate reduction in cardiovascular disease and therapy.
@en
P2093
Florian Custodis
Jan-Christian Reil
Jeffrey S Borer
Michael Böhm
Ulrich Laufs
P2860
P2888
P356
10.1007/S00392-010-0207-X
P577
2010-09-01T00:00:00Z